Diagnostics and Therapeutics Advances for Autoimmune Disorders (Technical Insights)

 


This research service outlines the key diagnostics and therapeutics for autoimmune disorders.

Regular Price: USD 4,950

Special Price USD 3,465

30% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 3,465

PAY BY INVOICE

Be the first to review this product

Table of Contents

Diagnostics and Therapeutics Advances for Autoimmune Disorders (Technical Insights), Executive SummaryIndustry Overview and Research HighlightsOverview of the Autoimmune Diagnostic and Therapeutic IndustryKey Research FindingsScope and MethodologyScope and SegmentationMethodologyDiagnostics and Therapeutics Advances for Autoimmune Disorders (Technical Insights), Technology Primer; Trends and Adoption FactorsBody versus Immune SystemThe Immune System--A Paradox of ComplexitiesThe Raging Battle within the Immune SystemRegulations and Mergers and AcquisitionsRegulations Across the IndustryNotable Mergers and Acquisitions in the IndustryDiagnostics and Therapeutics Advances for Autoimmune Disorders (Technical Insights), The World of Diagnostics for Autoimmune DisordersDiagnosis of Autoimmune DisordersA Sneak Preview of Autoimmune DiagnosticsEmerging Trends in Autoimmune DiagnosticsNoteworthy Innovations across the GlobeCorporate Initiatives for Autoimmune Disease DiagnosticsAssociation between Glutamate and Multiple SclerosisVitamin D Metabolites as Marker for Autoimmune Conditions Reduction in Antibody Rearrangements Can Lead to Onset of Autoimmune DiseasesGrowth Propelling Factors and Growth Repressing FactorsPropelling Factors for Autoimmune Diagnostic IndustryRepressing Factors for Autoimmune Diagnostic IndustryStrategic Analysis of the Autoimmune Diagnostics IndustryPorter's Five ForcesStrategic Recommendations Diagnostics and Therapeutics Advances for Autoimmune Disorders (Technical Insights), Therapeutics--A Long Road that Still Remains to be ExploredOverview of Therapies for Autoimmune DisordersCurrently Existing Therapies for Autoimmune DisordersCurrently Existing Drug Targets and Recent Trends in TherapeuticsNoteworthy Innovations across the Globe--Industrial InitiativesPeptide-Based Therapeutic Vaccine for Coeliac DiseaseTherapy for Type 1 Diabetes That Addresses Underlying Disease Mechanism Reduction in the Incidence of Relapses in RRMS A Novel Vaccine for Autoimmune Diabetes Peptide That Prevents the Destruction of Beta Cells Novel Small Molecule Drug Candidate for the Treatment of Rheumatoid ArthritisAntibody-Based Drug for Treating Autoimmune ComplicationsNoteworthy Innovations across the Globe--AcademiaBuckyball-Derived Therapeutics for Multiple Sclerosis Two Distinct Mechanisms Controls Treg Formation Transgenic Tobacco Plants Produce IL-10 A Potential Drug Target for Multiple SclerosisStem Cell Transplantation for Type 1 Diabetes Mellitus Breakthrough Research Could Yield Potential Treatment for Rheumatoid Arthritis T-regs--A New Concept in Treating Autoimmune Diseases Strategic Analysis of the Autoimmune Therapeutics IndustrySWOT Analysis of the Autoimmune Therapeutics IndustrySuggested Strategies for Success Diagnostics and Therapeutics Advances for Autoimmune Disorders (Technical Insights), Patents and Key ParticipantsPatentsPatents on DiagnosticsPatents on TherapeuticsKey ParticipantsIndustry ParticipantsAcademic ParticipantsDiagnostics and Therapeutics Advances for Autoimmune Disorders (Technical Insights), Decision Support DatabaseDSD TablesPharmaceutical R&D Expenditure (Million USD)--World (2002 to 2012)Percent Pharmaceutical R&D Expenditure--World (2002 to 2012)New Cases of Diabetes--World (2002 to 2012)Diabetes Prevalence--World (2002 to 2012)Total Cases of Multiple Sclerosis--World (2002 to 2012)




Related Research

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.